LONGITUDINAL EFFECTS OF TREATMENT ON BRAIN FUNCTION IN CHILDREN WITH TOURETTE SYN

描述（由申请人提供）：抽动秽语综合征（TS）是一种常见的遗传性儿童神经精神疾病。表现为慢性运动和声音抽搐，影响约0.3-1%的儿童，对生活质量有显著的负面影响。TS与冲动调节和执行控制功能的缺陷有关。大脑的执行控制系统被认为在解剖学上与下游的即时处理系统是分开的，并且由功能不同的区域组成。这些控制系统与处理系统的相互作用与TS有关。这一探索性提议的一个关键思想是，TS源于控制区域网络的非典型发展及其相互作用，而不是任何特定大脑区域的非典型功能。缓解抽搐的药物也可能导致控制能力的改善，并使控制区域内的诱发活动和组成控制网络的区域之间的功能连接正常化。我们假设，治疗TS的药物可以改善TS中观察到的大脑激活和功能连接的异常模式，了解药物对大脑控制网络的影响可能为TS和其他儿童神经精神疾病的早期诊断和更有效的治疗奠定基础。

DESCRIPTION (provided by applicant): Tourette Syndrome (TS) is a common genetic pediatric neuropsychiatric disorder. Manifest as chronic motor and vocal tics, it affects approximately 0.3-1% of children, with significant negative impact on quality of life. TS is associated with deficits in impulse regulation and executive control functions. The brain's executive control systems are thought to be anatomically separate from downstream moment-to-moment processing systems and to consist of networks of functionally diverse regions. The interactions of these control systems with processing systems have been implicated in TS. A key idea underlying this exploratory proposal is that TS arises from the atypical development of networks of control regions and their interactions, as opposed to the atypical functioning of any particular brain region. Medications that relieve tics in TS may also result in an improvement in control abilities, and a normalization of both evoked activity within control regions and of functional connectivity between regions comprising control networks. We hypothesis that the anomalous patterns of brain activation and functional connectivity observed in TS will be ameliorated by medications that treat TS. Understanding the brain's control networks are affected by medications may lay the foundation for earlier diagnosis and more effective therapies for TS and other pediatric neuropsychiatric disorders. PUBLIC HEALTH RELEVANCE: This proposal aims to use longitudinal task-based fMRI and functional connectivity MRI to characterize the development of control networks in pediatric Tourette Syndrome and how those networks respond to pharmacotherapeutic intervention. Understanding how networks of brain regions involved in control are affected by pharmacotherapy in patient with Tourette Syndrome may lay the foundation for earlier diagnosis, more accurate prognosis, and more effective therapies